The Motley Fool··Reuben Gregg BrewerPfizer's Comeback Play: GLP-1 Pivot and 6.2% Yield Appeal to Long-Term Investors
Pfizer pursues GLP-1 market opportunity through acquisition after internal failure, offering 6.2% dividend yield amid 50% stock decline from 2021 peaks.
PFELLYNVOdividend yieldGLP-1 drugs